---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-25-035251"
form_type: "8-K"
ticker: "RCKT"
cik: "0001281895"
company_name: "ROCKET PHARMACEUTICALS, INC."
filed_at: "2025-09-17T23:59:59+00:00"
generated_at: "2026-05-17T06:20:23.074260+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Rocket Pharma finalizes Dr. Patel separation; consulting through Dec 2026 with $582K retainer

## Summary
- Dr. Kinnari Patel receives $482,040 lump-sum severance (10 months salary) and $30,045 healthcare allowance.
- She stays on paid garden leave through Dec 31, 2025; then consulting until Dec 31, 2026 for $582,156 retainer.
- Patel retains restricted stock units and options during the consulting period under existing plans.
- Accrued PTO payout of $102,480; 2025 bonus eligibility subject to company performance.
- Payments conditioned on release of claims, non-disparagement, and restrictive covenant compliance.

## SEC filing metadata
- accession: 0001140361-25-035251
- form_type: 8-K
- ticker: RCKT
- cik: 0001281895
- company_name: ROCKET PHARMACEUTICALS, INC.
- filed_at: 2025-09-17T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1281895/000114036125035251/0001140361-25-035251-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1281895/000114036125035251/ef20055707_form8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-25-035251
- JSON: https://secwatch.observer/filing/0001140361-25-035251.json
- Plain text: https://secwatch.observer/filing/0001140361-25-035251.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.